Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,47%
1 067,36
+4,96
+0,47%
—1 062,401 064,141 071,991 061,02——
SIXC
Communications
SIXC
Communications
SIXC
-0,54%
603,48
-3,26
-0,54%
—606,74606,74609,84602,33——
SIXE
Energy
SIXE
Energy
SIXE
+0,54%
1 244,93
+6,72
+0,54%
—1 238,211 236,601 247,741 232,10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,68%
1 730,38
+11,77
+0,68%
—1 718,611 723,231 741,481 717,47——
SIXM
Financials
SIXM
Financials
SIXM
+0,33%
639,47
+2,10
+0,33%
—637,37638,27642,30638,27——
SIXR
Staples
SIXR
Staples
SIXR
+0,16%
854,95
+1,36
+0,16%
—853,59854,05858,19851,34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,11%
218,56
+0,23
+0,11%
—218,33218,33219,73217,15——
SIXT
Technology
SIXT
Technology
SIXT
+1,02%
3 631,59
+36,78
+1,02%
—3 594,813 620,103 657,473 615,34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,80%
915,77
+7,23
+0,80%
—908,54909,50917,35907,07——
SIXV
Health care
SIXV
Health care
SIXV
+1,19%
1 512,81
+17,81
+1,19%
—1 495,001 499,611 517,101 499,61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,41%
2 408,21
+9,90
+0,41%
—2 398,312 406,822 421,802 404,22——
OTLC:OTCMKTS
Oncotelic Therapeutics Inc
USD 0,058
+3,65%
(+0,0020) 1D
22 Mei, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLC...
Open
USD 0,05
High
USD 0,06
Low
USD 0,05
Mkt. cap
24,08 m
Avg. vol.
308,82 k
Volume
210,47 k
P/E ratio
0,10
52-wk high
USD 0,11
52-wk low
USD 0,02
EPS
USD 0,55
Beta
-0,54
Shares outstanding
444,50 m
No. of employees
41
News stories
From sources across the web
About Oncotelic Therapeutics Inc
CEO-
Employees41
Founded1988
HeadquartersSouth San Francisco, Kalifornië, Verenigde State van Amerika
Sector-
Websiteoncotelic.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
297,00
426,00
3,34 k
795,00
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
65,67 k
490,55 k
2,33 m
1,85 m
Operating expense
65,97 k
490,97 k
2,33 m
1,85 m
Total operating expenses
65,97 k
490,97 k
2,33 m
1,85 m
Operating income
-65,97 k
-490,97 k
-2,33 m
-1,85 m
Other non operating income
484,20 k
-392,06 k
326,43 k
-90,08 k
EBT including unusual items
210,45 k
-1,11 m
361,84 m
-2,24 m
EBT excluding unusual items
210,45 k
-1,11 m
-2,24 m
-2,24 m
Income tax expense
-
-
111,55 m
-
Effective tax rate
-
-
30,83%
-
Other operating expenses
-
-
-
-
Net income
277,86 k
-1,05 m
250,35 m
-2,19 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-207,78 k
-231,34 k
-242,57 k
-295,81 k
Net interest expenses
-207,78 k
-231,34 k
-242,57 k
-295,81 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer